Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
2017 · Annals of Oncology · 189 citations
https://doi.org/10.1093/annonc/mdx112
J
José María Viéitez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
3.9K
Citations
23
h-index
36
i10-index
José María Viéitez is an academic researcher from Hospital Universitario Central de Asturias. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics. The author has an h-index of 23, co-authored 101 publications.
Papers by this author
worksLauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
2017 · British Journal of Cancer · 99 citations
https://doi.org/10.1038/bjc.2017.245
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial
2020 · ESMO Open · 59 citations
https://doi.org/10.1136/esmoopen-2020-000944
CISNE: An accurate description of dose-effect and synergism in combination therapies
2018 · Scientific Reports · 56 citations
https://doi.org/10.1038/s41598-018-23321-6
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015
2015 · Clinical & Translational Oncology · 34 citations
https://doi.org/10.1007/s12094-015-1434-4
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
2021 · Drugs & Aging · 7 citations
https://doi.org/10.1007/s40266-021-00834-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat